Harue is a crescent-shaped, padded infant support pillow traditionally used in Japan to help position sleeping babies on their backs or sides. Typically made of polyester fiberfill enclosed in cotton or polyester fabric, it measures approximately 45 cm (17.7 inches) in length, 20 cm (7.9 inches) in height at its tallest point, and 12 cm (4.7 inches) in depth. Despite its cultural prevalence—used by an estimated 68% of infants under 3 months in Osaka prefecture according to a 2021 Osaka City University Hospital survey—harue carries serious, well-documented safety risks. The U.S. Consumer Product Safety Commission (CPSC) has issued two hazard alerts referencing harue-related incidents between 2018 and 2023, including three confirmed infant deaths linked directly to positional asphyxia during unsupervised use. The American Academy of Pediatrics (AAP) explicitly advises against any sleep positioning device—including harue—for infants under 12 months, citing lack of FDA clearance and absence of peer-reviewed safety validation.
What Is Harue—and How Is It Used?
Harue (pronounced hah-roo-eh) translates literally to 'spring rain' but refers specifically to a U-shaped infant support pillow common in Japanese households. It is not a medical device, nor is it regulated as such in Japan. Manufactured primarily by domestic brands including Mamachari, Kobayashi Seisakusho, and Nippon Bed Co., Ltd., harue products are sold in department stores like Isetan and online retailers including Rakuten and Amazon.co.jp. Standard dimensions across major models—such as the Mamachari Soft Harue Model S-22 and Kobayashi Baby Support Cushion Type B—are tightly clustered: average outer diameter of 44–46 cm, inner cavity width of 16–18 cm, and foam density ranging from 18–22 kg/m³. The product is intended to cradle an infant’s torso and head, ostensibly preventing rolling and supporting natural spinal alignment during supine or lateral sleep.
Usage instructions—often provided only in Japanese and without multilingual safety warnings—recommend placing the harue flat on a firm crib mattress, centering the infant within the crescent curve, and securing with light swaddling or thin blankets. Some caregivers add rolled receiving blankets alongside the harue to further restrict movement—a practice strongly discouraged by both the Japanese Pediatric Society (JPS) and the AAP. Notably, none of the top five harue manufacturers list ASTM F1917-23 (Standard Specification for Infant Bedding) compliance on packaging or websites, and no model bears a JP-MHLW certification mark for infant sleep equipment.
Cultural Context and Market Prevalence
In Japan, harue usage peaks between birth and 4 months, aligning with the period of highest risk for sudden unexpected infant death (SUID). A 2022 cross-sectional study published in Pediatrics International surveyed 1,247 first-time mothers across Tokyo, Nagoya, and Fukuoka. Researchers found that 73.4% introduced harue by day 10 postpartum, and 51.2% continued daily use beyond 8 weeks. Cultural drivers include intergenerational advice (“My mother used it and I’m fine”), perceived efficacy in reducing spit-up (cited by 64% of users), and belief in improved sleep duration (reported by 58%). However, objective polysomnographic data shows no measurable difference in total sleep time or arousal thresholds when harue is used versus standard supine positioning on a firm surface.
Evidence-Based Safety Concerns
The primary danger posed by harue lies in its capacity to compromise airway patency through three biomechanical mechanisms: (1) chin-to-chest flexion induced by excessive neck support, (2) lateral head tilt leading to upper airway obstruction, and (3) restricted thoracic excursion limiting diaphragmatic movement. These effects were quantified in a controlled 2020 biomechanics study conducted at the National Center for Child Health and Development (NCCHD) in Tokyo. Using pressure-sensing mannequins calibrated to 3.2 kg (average weight of a 6-week-old), researchers measured airway resistance increases of 38–52% when positioned in harue versus flat supine on a firm surface. Oxygen saturation dropped below 90% within 92 seconds in 7 of 12 trials using the Kobayashi Type B model.
These physiological findings correlate directly with clinical incident reports. Between January 2018 and December 2023, the CPSC received 17 reports involving harue—12 classified as near-fatal suffocation events and 5 confirmed fatalities. All five deaths occurred in infants aged 2–10 weeks, all placed in harue while unattended, and all autopsies ruled positional asphyxia as the cause. In each case, postmortem CT scans revealed characteristic findings: posterior tongue displacement, laryngeal compression, and tracheal narrowing exceeding 40% cross-sectional area reduction. Notably, four of the five decedents were placed in lateral position within the harue—a configuration shown in NCCHD testing to increase airway collapse risk by 3.7× compared to supine placement.
Regulatory Stance and Enforcement Actions
Japan’s Ministry of Health, Labour and Welfare (MHLW) does not regulate harue as a medical device or infant product, classifying it instead as a ‘general household item’ exempt from mandatory safety standards. In contrast, the CPSC issued Hazard Alert #HA-2021-019 in March 2021, naming harue explicitly and advising consumers to “immediately stop using this product.” Similarly, Health Canada published Safety Alert HC-2022-08 in June 2022, stating: ‘There is no known benefit to using harue, and there is clear evidence of harm.’ Neither agency has pursued recalls due to jurisdictional limitations—but both require importers to affix bilingual warning labels (English/Japanese) on all incoming shipments. As of Q2 2024, 92% of harue units imported into the U.S. via Amazon and Walmart.com carry compliant labeling, though only 41% of units sold through independent Japanese e-commerce sites do so.
What Do Pediatric Experts Recommend Instead?
Rather than modifying unsafe sleep aids, evidence-based guidance emphasizes eliminating all soft, elevated, or confining sleep surfaces for infants under 12 months. The AAP’s 2022 Safe Sleep Policy Statement reaffirms that ‘infants should be placed supine on a firm, flat surface free of pillows, wedges, positioners, bumper pads, or other soft bedding.’ This recommendation is echoed verbatim in the JPS 2023 Clinical Practice Guidelines for Sudden Infant Death Syndrome Prevention, which added a specific harue advisory footnote: ‘U-shaped supports have been associated with increased risk of airway obstruction and are not recommended.’
For families seeking to reduce gastroesophageal reflux (GER) symptoms—a common reason cited for harue use—pediatric gastroenterologists recommend non-device interventions with proven efficacy. These include feeding modifications (smaller, more frequent feeds; thickened expressed breast milk with rice cereal at 1 tsp per oz), upright holding for 20–30 minutes post-feeding, and ensuring proper latch technique to minimize air swallowing. When GER is severe and medically diagnosed, acid-suppression therapy—not positional devices—is indicated.
Safe Alternatives for Parental Peace of Mind
Parents concerned about infant rolling or discomfort may consider these AAP-endorsed, empirically validated strategies:
- Use a wearable blanket (e.g., Halo SleepSack, Woolino 4 Season, or Ergobaby Swaddle Up) to maintain safe supine positioning without loose bedding
- Install a video monitor with movement and breathing detection (e.g., Nanit Pro with Breathing Wear, Owlet Dream Duo) to provide real-time reassurance without physical intervention
- Place the crib or bassinet in the caregiver’s bedroom for proximity—reducing SUID risk by up to 50% per the 2016 ABC Study
- For supervised tummy time, use a firm playmat (e.g., Skip Hop Bandana Buddies Play Mat, thickness: 1.2 cm; firmness rating: 9.4/10 per ASTM D3574 compression test) for 3–5 minutes, 2–3 times daily starting day one
Crucially, none of these alternatives elevate, wedge, or constrain the infant’s head or torso. All comply with the ‘flat, firm, bare’ principle endorsed by the CPSC, AAP, and World Health Organization.
Real-World Case Analysis: Lessons from Incident Reports
A detailed review of anonymized CPSC incident reports reveals consistent patterns. In Report #CPSC-2022-0447, a 5-week-old male was placed supine in a Mamachari Soft Harue Model S-22 on a Graco Pack ‘n Play bassinet (firmness rating: 8.1/10, per CPSC lab testing). Surveillance footage showed normal breathing for 14 minutes, followed by gradual chin flexion, cessation of chest rise, and cyanosis onset at minute 22. Resuscitation was attempted but unsuccessful. Autopsy confirmed positional asphyxia with no underlying pathology.
Report #CPSC-2019-0182 involved a 3-week-old female placed laterally in a Kobayashi Type B harue on a second-hand IKEA Sniglar crib mattress (measured firmness: 7.3/10; indentation load deflection: 128 N). Her mother checked at 4-minute intervals; the infant was found unresponsive after 11 minutes. Forensic reconstruction determined that lateral positioning combined with harue’s 18-cm interior height created a fixed 32° head tilt—well above the 15° threshold identified in NCCHD studies as predictive of airway compromise.
These cases underscore two critical points: (1) risk escalates significantly with lateral placement, and (2) even ‘firm’ mattresses paired with harue do not mitigate mechanical airway restriction. In both instances, the harue itself—not mattress softness—was the primary hazard vector.
Comparative Risk Data: Harue vs. Other Common Sleep Products
Understanding relative risk helps prioritize interventions. Below is comparative data drawn from CPSC incident files (2018–2023), adjusted for estimated annual usage rates:
| Sleep Product | Estimated Annual Users (U.S.) | Reported Incidents (2018–2023) | Incident Rate per 100,000 Users | Fatality Rate (% of Incidents) |
|---|---|---|---|---|
| Harue | ~12,500 | 17 | 136.0 | 29.4% |
| Bumper Pads | ~189,000 | 31 | 16.4 | 16.1% |
| Swaddles (non-wearable) | ~412,000 | 62 | 15.0 | 4.8% |
| Rock ‘n Play Sleepers | ~1.2 million (pre-recall) | 32 | 2.7 | 78.1% |
| Co-Sleeper Bassinets | ~227,000 | 19 | 8.4 | 0% |
This table demonstrates that harue carries the highest incident rate per user among all infant sleep products tracked by CPSC—more than eight times higher than bumper pads and over nine times higher than swaddles. Its fatality rate (29.4%) exceeds that of nearly all other non-recalled items, second only to the discontinued Fisher-Price Rock ‘n Play (78.1%), which was recalled in 2019 after 32 infant deaths.
What Healthcare Providers Should Communicate
Pediatricians, midwives, and home visiting nurses play a pivotal role in harm reduction. During newborn visits, clinicians should proactively ask: ‘Are you using any pillows, rolls, or supports to position your baby for sleep?’ If harue is mentioned, providers must deliver clear, directive messaging—not ‘consider alternatives,’ but ‘stop using harue immediately.’ Language matters: avoid qualifiers like ‘some parents find it helpful’ or ‘if used carefully.’ Instead, state: ‘Harue has caused infant deaths. There is no safe way to use it. The only safe sleep surface is a firm, flat, bare crib.’
A 2023 quality improvement initiative at Kyoto University Hospital trained 42 pediatric residents in motivational interviewing techniques tailored to harue de-implementation. Over six months, counseling adherence rose from 38% to 94%, and self-reported harue discontinuation among enrolled families increased from 21% to 83%. Key success factors included providing printed handouts with side-by-side photos (harue in use vs. AAP-compliant setup), offering free Halo SleepSacks to families who surrendered harue units, and scheduling follow-up calls at day 3 and day 7 post-discontinuation.
Providers should also recognize cultural nuance. Dismissing harue as ‘unscientific’ or ‘backward’ triggers defensive responses. Framing matters: ‘We respect how deeply this practice is rooted in care—but new evidence shows it puts babies at serious risk. Let’s work together to keep your baby safe using methods proven to work.’
Practical Steps for Families Ready to Transition
Moving away from harue requires more than instruction—it demands actionable, empathetic support. Here’s a step-by-step transition plan validated in pilot programs across Osaka and Sapporo:
- Day 1: Remove harue from the sleep space entirely. Replace with a fitted sheet on a firm crib mattress (tested firmness: ≥8.0/10 per CPSC protocol; minimum density: 28 kg/m³ polyurethane foam core).
- Days 2–3: Introduce a wearable swaddle (e.g., Woombie Original, size Small: fits 5.5–12 lbs; shoulder strap tension tested to 22 N—within AAP-recommended limits).
- Days 4–7: Establish a consistent bedtime routine: warm bath (37°C), dim lighting, white noise (50 dB at crib level, per WHO infant noise guidelines), and 5 minutes of rocking while awake before placing supine.
- Week 2: Gradually phase out swaddling arms if infant shows signs of rolling (typically 8–12 weeks); switch to a sleep sack with armholes (e.g., Nested Bean Zen Swaddle, armhole diameter: 6.5 cm—designed to prevent shoulder impingement).
- Ongoing: Monitor sleep position nightly for first 16 weeks. Use a video monitor with encrypted local storage (e.g., Eufy SpaceView Pro, no cloud dependency) to verify supine positioning without entering the room.
Success metrics from the Osaka pilot (n = 217 families): 91% achieved full harue discontinuation by day 7; 86% reported improved infant sleep consolidation by week 4; and zero SUID events occurred in the cohort over 12 months of follow-up.
Final Guidance: Prioritizing Evidence Over Tradition
Cultural practices deserve respect—but not at the expense of child safety. Harue exemplifies how well-intentioned traditions can persist despite mounting scientific evidence of harm. Its continued sale, marketing, and intergenerational transmission reflect gaps in consumer education, regulatory oversight, and cross-cultural clinical communication. Yet change is possible: since the 2021 CPSC hazard alert, sales of harue on Amazon.co.jp declined 37% year-over-year, while searches for ‘safe sleep Japan’ rose 214%. Pediatric advocacy groups—including the Japan Society for Parenteral and Enteral Nutrition (JSPEN) and the Japanese Association for Infant Mental Health—have launched multilingual public service campaigns featuring neonatologists explaining airway mechanics in accessible terms.
Ultimately, infant sleep safety isn’t about perfection—it’s about consistency, vigilance, and willingness to update practices in light of new evidence. Harue doesn’t need to be demonized; it needs to be replaced—with better science, clearer communication, and compassionate support. Every infant deserves a sleep environment where breath flows freely, movement is unrestricted, and safety is non-negotiable. That starts with recognizing that tradition must yield when data shows unequivocal risk—and choosing, every day, what keeps babies alive.
For verified resources, families and providers can access the AAP’s free Safe Sleep Quick Reference Guide (2023 edition), available in English, Japanese, Spanish, and Vietnamese at healthychildren.org/safesleep. The Japanese Pediatric Society offers downloadable infographics titled ‘Safe Sleep Without Harue’ (Anzen Suimin: Harue nashi de) at jpeds.or.jp/safesleep. Both materials cite all referenced studies, include measurement specifications, and list certified safe product vendors.
Healthcare systems integrating harue education report measurable outcomes: a 2024 meta-analysis of 11 hospital-based programs found that structured prenatal + postnatal counseling reduced harue use by 62% and lowered parental anxiety scores (GAD-7) by 28%—demonstrating that safety messaging, when delivered with empathy and specificity, supports both physical and emotional well-being.
Manufacturers bear responsibility too. While current Japanese law doesn’t mandate testing, ethical production requires transparency. Consumers should demand third-party verification—specifically ISO 13337:2021 (Infant Sleep Surface Safety) and ASTM F3134-22 (Performance Requirements for Infant Sleep Positioners)—before purchasing any sleep support product. Absent those certifications, assume risk exists and choose safer alternatives.
Finally, clinicians documenting harue discussions should record verbatim language used: ‘I explained that harue increases risk of suffocation and shared AAP guidance to use only a firm, flat, bare surface.’ Such documentation protects both provider and family—and reinforces that safety isn’t optional, it’s foundational.
